Jillian B. Thomsen, SVP & Chief Accounting Officer at NEKTAR THERAPEUTICS (NKTR), sold 2,363 shares at $10.95 ($26K) on 2022-02-16, disclosed to the SEC on 2022-02-18.
Seasonal sale ($26k) by SVP & Chief Accounting Officer — this insider has traded NKTR in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| NKTR | SELL | 2022-08-17 | $10K | — | Filing → |
| NKTR | SELL | 2022-05-17 | $23K | — | Filing → |
| NKTR | SELL | 2021-11-17 | $177K | — | Filing → |